Role of the chemokine receptors CCR3 and CXCR2 in chemoresistant gastric cancer: a potential coadjuvant therapy in treatments based on cisplatin and 5-fluorouracil drugs
Más información
| Fecha de publicación: | 2021 |
| Objetivos: | To evaluate how the chemokine receptors CCR3 and CXCR2 induces the cisplatin and 5-fluorouracil drug-resistant phenotype by using in vitro and in vivo gastric cancer models |
| Instrumento: | FONDECYT |
| Año de Inicio/Término: | 2021-2024 |
| Financiamiento/Sponsor: | CONICYT |
| Rol del Usuario: | INVESTIGADOR(A) RESPONSABLE |
| DOI: |
3210629 |